Jonathan Siegal, Principal Accounting Officer of Vericel Corp (NASDAQ:VCEL), filed a Form 4 on November 6, 2026, disclosing a stock option exercise and a same-day sale of 1,500 shares of common stock on November 5, 2026.

Key Highlights

  • Option exercise: Siegal exercised a stock option to acquire 1,500 shares of common stock at an exercise price of $34.90 per share on November 5, 2026.
  • Shares sold: 1,500 shares were disposed of at $52.90 per share on November 5, 2026, pursuant to a Rule 10b5-1 trading plan.
  • 10b5-1 plan: According to the filing, the sale was effected automatically under a Rule 10b5-1 trading plan the reporting person adopted on December 10, 2025.
  • Remaining beneficial ownership: Following the transactions, Siegal directly held 1,259 shares of common stock and 1,198 stock options.
  • Option details: The exercised options had an expiration date of February 18, 2032, and originally represented the right to purchase 4,198 shares, vesting in equal quarterly installments beginning May 18, 2022.
  • ESPP footnote: The filing notes that shares reported include shares acquired under the issuer's 2015 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(d) and Rule 16b-3(c).

Vericel Corp Principal Accounting Officer Reports Option Exercise and Automated Share Sale

Jonathan Siegal, identified in the filing as Principal Accounting Officer of Vericel Corp, reported two transactions in Table I on November 5, 2026. First, he acquired 1,500 shares of common stock through a stock option exercise (transaction code M) at a price of $34.90 per share. Immediately following, 1,500 shares were sold (transaction code S) at $52.90 per share. The filing also reflects a corresponding disposition of 1,500 derivative securities in Table II under the same exercise transaction.

The filing states that the sale "was effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025." The Form 4 header confirms that the box indicating a transaction made pursuant to a Rule 10b5-1(c) plan was checked. Following both transactions, Siegal's direct beneficial ownership of common stock stood at 1,259 shares, and his remaining stock option position was reported as 1,198 options.

The exercised options were described in the filing as originally representing the right to purchase 4,198 shares, becoming exercisable "in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted." The form was signed by Sean Flynn as Attorney-in-Fact for Jonathan Siegal and filed on November 6, 2026.

What Was Disclosed

The filing reports a November 5, 2026 stock option exercise at $34.90 and a same-day sale of 1,500 Vericel Corp shares at $52.90, executed under a pre-established Rule 10b5-1 plan, leaving Siegal with direct ownership of 1,259 shares.